{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70748-274",
      "generic_name": "Ganirelix Acetate",
      "labeler_name": "Lupin Pharmaceuticals, Inc.",
      "brand_name": "Ganirelix Acetate",
      "active_ingredients": [
        {
          "name": "GANIRELIX ACETATE",
          "strength": "250 ug/.5mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70748-274-01",
          "description": "1 TRAY in 1 CARTON (70748-274-01)  / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20240214",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "855200"
        ],
        "spl_set_id": [
          "e50888ef-5e66-4b15-bdc3-2f6794f09246"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0370748274019"
        ],
        "unii": [
          "56U7906FQW"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "c0fdd470-a16f-41c4-9bfa-4240b6ff67e7",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20240214",
      "product_id": "70748-274_c0fdd470-a16f-41c4-9bfa-4240b6ff67e7",
      "application_number": "ANDA216075",
      "brand_name_base": "Ganirelix Acetate",
      "pharm_class": [
        "Decreased GnRH Secretion [PE]",
        "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]",
        "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]"
      ]
    }
  ]
}